279 related articles for article (PubMed ID: 12494093)
1. [Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus].
Reshetniak TM; Kotel'nikova GP; Fomicheva OA; Kliukvina NG; Karpov IuA; Alexandrova EN; Alekberova ZS; Sergakova LM; Nasonova VA; Nasonov EL
Kardiologiia; 2002; 42(8):38-43. PubMed ID: 12494093
[TBL] [Abstract][Full Text] [Related]
2. [Involvement of cardiac valves in antiphospholipid syndrome].
Sergakova LM; Fomicheva OA; Vil'chinskaia MI; Alekberova ZS; Aleksandrova EN; Karpov IA; Nasonov EL; At'kov OI
Klin Med (Mosk); 1996; 74(9):39-42. PubMed ID: 9121087
[TBL] [Abstract][Full Text] [Related]
3. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies.
Gabrielli F; Alcini E; Di Prima MA; Mazzacurati G; Masala C
Int J Cardiol; 1995 Sep; 51(2):117-26. PubMed ID: 8522406
[TBL] [Abstract][Full Text] [Related]
4. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.
Hojnik M; George J; Ziporen L; Shoenfeld Y
Circulation; 1996 Apr; 93(8):1579-87. PubMed ID: 8608627
[TBL] [Abstract][Full Text] [Related]
5. Patients with systemic lupus erythematosus and antiphospholipid syndrome undergoing cardiac valve surgery.
Arif R; Farag M; Seppelt P; Beller CJ; Ruhparwar A; Karck M; Kallenbach K
J Heart Valve Dis; 2015 Mar; 24(2):228-35. PubMed ID: 26204691
[TBL] [Abstract][Full Text] [Related]
6. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis.
Watad A; Tiosano S; Grysman N; Comaneshter D; Cohen AD; Shoenfeld Y; Amital H
Eur J Clin Invest; 2017 May; 47(5):366-371. PubMed ID: 28295225
[TBL] [Abstract][Full Text] [Related]
7. The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement.
Amoroso A; Cacciapaglia F; De Castro S; Battagliese A; Coppolino G; Galluzzo S; Vadacca M; Afeltra A
Clin Exp Rheumatol; 2006; 24(3):287-94. PubMed ID: 16870096
[TBL] [Abstract][Full Text] [Related]
8. [Cardiac anomalies in disseminated lupus erythematosus diagnosed by Doppler ultrasonography. Prevalence and association with antiphospholipid syndrome].
Metz D; Jolly D; Graciet-Richard J; Pennaforte JL; Nazeyrollas P; Chabert JP; Elaerts J; Etienne JC
Presse Med; 1994 Dec; 23(39):1797-802. PubMed ID: 7899300
[TBL] [Abstract][Full Text] [Related]
9. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus.
Leung WH; Wong KL; Lau CP; Wong CK; Liu HW
Am J Med; 1990 Oct; 89(4):411-9. PubMed ID: 2121029
[TBL] [Abstract][Full Text] [Related]
10. [Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus].
Hosaka K; Okada J; Ogiwara A; Kobayashi A; Kondo H
Ryumachi; 1994 Feb; 34(1):22-9. PubMed ID: 8146724
[TBL] [Abstract][Full Text] [Related]
11. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.
Perez-Villa F; Font J; Azqueta M; Espinosa G; Pare C; Cervera R; Reverter JC; Ingelmo M; Sanz G
Arthritis Rheum; 2005 Jun; 53(3):460-7. PubMed ID: 15934103
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease.
Bulckaen HG; Puisieux FL; Bulckaen ED; Di Pompeo C; Bouillanne OM; Watel AA; Fauchais AL; De Groote P; Millaire A
Mayo Clin Proc; 2003 Mar; 78(3):294-8. PubMed ID: 12630582
[TBL] [Abstract][Full Text] [Related]
13. [Atheroscleotic vascular lesion in systemic lupus erythematosus and antiphospholipid syndrome in men].
Il'ina AE; Kliukvina NG; Aleksandrova EN; Popkova TV; Novikov AA; Mach ES; Bulgakova OV; Nasonov EL
Klin Med (Mosk); 2006; 84(4):23-8. PubMed ID: 16755850
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: a matched echocardiographic study.
Metz D; Jolly D; Graciet-Richard J; Nazeyrollas P; Chabert JP; Maillier B; Pennaforte JL; Elaerts J
Cardiology; 1994; 85(2):129-36. PubMed ID: 7954564
[TBL] [Abstract][Full Text] [Related]
15. [The diagnosis and treatment of a secondary antiphospholipid syndrome in systemic lupus erythematosus].
Komarov VT
Ter Arkh; 1998; 70(8):65-6. PubMed ID: 9770752
[TBL] [Abstract][Full Text] [Related]
16. Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome.
Hayem G; Nicaise-Roland P; Palazzo E; de Bandt M; Tubach F; Weber M; Meyer O
Lupus; 2001; 10(5):346-51. PubMed ID: 11403265
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic findings in asymptomatic systemic lupus erythematosus patients.
Mohammed AG; Alghamdi AA; ALjahlan MA; Al-Homood IA
Clin Rheumatol; 2017 Mar; 36(3):563-568. PubMed ID: 27866289
[TBL] [Abstract][Full Text] [Related]
18. Valvular lesions in patients with systemic lupus erythematosus and antiphospholipid syndrome: an old disease but a persistent challenge.
Ferreira E; Bettencourt PM; Moura LM
Rev Port Cardiol; 2012 Apr; 31(4):295-9. PubMed ID: 22386150
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies.
Roldan CA; Shively BK; Lau CC; Gurule FT; Smith EA; Crawford MH
J Am Coll Cardiol; 1992 Nov; 20(5):1127-34. PubMed ID: 1341885
[TBL] [Abstract][Full Text] [Related]
20. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus.
Sabet A; Sibbitt WL; Stidley CA; Danska J; Brooks WM
Stroke; 1998 Nov; 29(11):2254-60. PubMed ID: 9804631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
